8.4 Common Traps in Medical Disorders

Disseminated Intravascular Coagulation (DIC)

DIC is a consumption coagulopathy: widespread activation of clotting consumes platelets and clotting factors, producing simultaneous microthrombosis and hemorrhage. The paradox—a patient who is both clotting and bleeding—is the trap, because answers that describe pure bleeding or pure clotting are wrong.

DIC is always secondary; common triggers are sepsis, obstetric catastrophes (abruption, amniotic fluid embolism), trauma, burns, and malignancy. The lab signature is tested directly:

Treatment is treat the underlying cause first, with supportive replacement of platelets, fresh frozen plasma, and cryoprecipitate (for fibrinogen) guided by bleeding and labs—not by numbers alone. A stem listing a low platelet count, low fibrinogen, prolonged PT/PTT, and a high D-dimer in a septic or post-partum patient is DIC until proven otherwise.

Distinguish DIC from its look-alikes. Immune thrombocytopenic purpura (ITP) lowers only the platelet count, leaving fibrinogen and clotting times normal. Thrombotic thrombocytopenic purpura (TTP) is a microangiopathy with the pentad of thrombocytopenia, hemolytic anemia with schistocytes, fever, renal dysfunction, and neurologic changes—but with normal PT/PTT and fibrinogen, which separates it from DIC and makes plasma exchange, not factor replacement, the treatment.

The discriminating question on the exam is whether fibrinogen is consumed and clotting times are prolonged: if yes, it is DIC; if the platelets are low but coagulation studies are normal, look to ITP or TTP instead.

Sickle Cell Crisis and Acute Chest Syndrome

In sickle cell disease, deoxygenated hemoglobin S polymerizes, sickling red cells and occluding microvasculature. A vaso-occlusive (pain) crisis brings severe bone, back, or joint pain, often precipitated by dehydration, infection, hypoxia, cold, or stress.

ED management of a pain crisis is straightforward but trap-laden:

• Prompt, adequate analgesia—often IV opioids; undertreating pain because of opioid bias is a classic error.
• Hydration with IV crystalloid.
• Oxygen for hypoxia and treatment of any precipitant.

The escalation to watch is acute chest syndrome (ACS), the leading cause of death in sickle cell disease. ACS is a new pulmonary infiltrate on chest X-ray plus fever and/or respiratory symptoms (chest pain, hypoxia, cough). A patient with vaso-occlusive pain who develops new hypoxia and an infiltrate has ACS, which adds antibiotics, supplemental oxygen, and often simple or exchange transfusion to the regimen. Calling new hypoxia a "GERD flare," "muscle strain," or "migraine" is the intended distractor.

Other sickle complications worth recognizing include aplastic crisis (a sudden drop in hemoglobin and reticulocytes, classically after parvovirus B19), splenic sequestration (rapid splenic pooling of blood with a falling hemoglobin and hypovolemic shock, mostly in young children), and priapism. Each is an emergency in its own right, so a falling hemoglobin in a sickle patient is never dismissed as expected baseline anemia.

Neutropenic Fever and Tumor Lysis Syndrome

Neutropenic fever is defined as an absolute neutrophil count (ANC) <500 cells/mm³ (or expected to fall below it) plus a single temperature ≥38.3°C (101°F) or ≥38.0°C sustained for an hour. With no functioning neutrophils, fever may be the only sign of overwhelming infection, so it is an emergency:

• Draw cultures, then give broad-spectrum antibiotics within 1 hour (an antipseudomonal beta-lactam such as cefepime or piperacillin-tazobactam).
• Do not wait for a repeat ANC, outpatient follow-up, or oral antipyretics alone—delay can be fatal.
• Add antifungal coverage if fever persists beyond 4–7 days.

Tumor lysis syndrome (TLS) follows rapid tumor breakdown—classically just after chemotherapy for bulky leukemias/lymphomas. Cell contents flood the blood, producing a fixed electrolyte quartet:

Hyperkalemia (arrhythmia) and hypocalcemia (tetany, seizures) are the lethal pieces. Prevent and treat with aggressive IV hydration, rasburicase (or allopurinol) to lower uric acid, and management of the electrolytes. Misreading TLS as simple dehydration is the trap.

Transfusion Reactions and Other Oncologic Emergencies

** An acute hemolytic reaction (usually ABO incompatibility) brings fever, flank or back pain, hemoglobinuria, hypotension, and a sense of impending doom within minutes—it can trigger DIC and renal failure, so after stopping the blood you provide fluids, support blood pressure, and notify the blood bank with the unit returned. Other reactions to recognize: febrile non-hemolytic (most common, treat with antipyretics), allergic/anaphylactic (urticaria to anaphylaxis—epinephrine if severe), and TRALI (acute respiratory distress within 6 hours).

The trap answer—"increase the rate to finish quickly" or "discard the bag before notifying anyone"—is always wrong.

Two more oncologic emergencies round out the domain. Superior vena cava (SVC) syndrome from a mediastinal tumor causes facial and upper-extremity swelling, distended neck veins, and dyspnea; it is an emergency when airway or cerebral edema threatens, managed with head elevation, oxygen, and oncology consultation for radiation or stenting. Hypercalcemia of malignancy presents with the "stones, bones, groans, and psychiatric overtones" and is treated with aggressive saline plus bisphosphonates.

Spinal cord compression from metastasis—back pain with new weakness, numbness, or bladder/bowel changes—is a time-critical emergency requiring urgent steroids (dexamethasone) and imaging. Recognizing these as emergencies rather than chronic complaints is exactly the judgment the trap questions probe.